Cargando…

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer

BACKGROUND: Esophageal cancer remains a disease with poor survival and many complications. Measuring muscle mass and quality can identify patients with diminished muscle mass (sarcopenia) and muscle fat infiltration (myosteatosis). We studied the impact of sarcopenia and myosteatosis in resectable e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srpcic, Matevz, Jordan, Taja, Popuri, Karteek, Sok, Mihael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276641/ https://www.ncbi.nlm.nih.gov/pubmed/32229679 http://dx.doi.org/10.2478/raon-2020-0016

Ejemplares similares

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
por: Petric, Miha, et al.
Publicado: (2023)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment
por: Ahern, Elizabeth, et al.
Publicado: (2023)

Sarcopenia after induction therapy is associated with reduced survival in patients undergoing esophagectomy for locally-advanced esophageal cancer
por: Wakefield, Connor J., et al.
Publicado: (2021)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

Diagnosing sarcopenia and myosteatosis based on chest computed tomography images in healthy Chinese adults
por: Tan, Lingling, et al.
Publicado: (2021)

Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis
por: Feng, Hongjuan, et al.
Publicado: (2021)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
por: Aro, Raila, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

The Prognostic Value of Sarcopenia and Myosteatosis in Biliary Tract Cancer After Palliative Treatment With Radiation-Emitting Metallic Stent
por: Chen, Qi, et al.
Publicado: (2022)

Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt
por: Yin, Liang, et al.
Publicado: (2023)

Myosteatosis in a systemic inflammation‐dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer
por: Gabiatti, Camila T. B., et al.
Publicado: (2019)

The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer
por: Booka, Eisuke, et al.
Publicado: (2015)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
por: Banierink, Hester, et al.
Publicado: (2021)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
por: Kim, Hong-Kyu, et al.
Publicado: (2023)

Sarcopenia and Myosteatosis Assessed by Magnetic Resonance Enterography May Predict Negative Outcomes in Patients with Crohn’s Disease
por: Eren Cankurtaran, Rasim, et al.
Publicado: (2023)

Clinical Nomogram for Predicting Survival of Esophageal Cancer Patients after Esophagectomy
por: Cao, Jinlin, et al.
Publicado: (2016)

The Impact of Postoperative Complications on Survivals After Esophagectomy for Esophageal Cancer: Erratum
Publicado: (2015)

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation
por: Czigany, Zoltan, et al.
Publicado: (2021)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
por: Nachit, Maxime, et al.
Publicado: (2020)

Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies
por: Cespiati, Annalisa, et al.
Publicado: (2022)

Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
por: Zhao, Zhiyong, et al.
Publicado: (2021)

Association of Medical Appointment Cancellation Rates on Survival After Esophagectomy for Esophageal Cancer
por: Knewitz, Daniel, et al.
Publicado: (2022)

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer
por: Wong, Lye-Yeng, et al.
Publicado: (2023)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort
por: Meister, Franziska Alexandra, et al.
Publicado: (2022)

The Influence of Pretherapeutic and Preoperative Sarcopenia on Short-Term Outcome after Esophagectomy
por: Grün, Johanna, et al.
Publicado: (2020)

Factors Affecting Blood Loss During Thoracoscopic Esophagectomy for Esophageal Carcinoma
por: Urabe, Masayuki, et al.
Publicado: (2021)

Quantifying brain metabolism from FDG‐PET images into a probability of Alzheimer's dementia score
por: Yee, Evangeline, et al.
Publicado: (2019)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l9k2t728lniu6uqbd7c313p161